Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of triptorelin (Diphereline) for final oocyte maturation trigger in infertile women undergoing antagonist IVF cycles
IRCT20190409043212N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triptorelin in infertility (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Fertility rate, Implantation rate and 8 more. Started Dec 2015; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20190409043212N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190409043212N2.